Crystal structures of botulinum neurotoxin dc in complex with its protein receptors synaptotagmin i and II

Structure

Volumn 21, Issue 9, 2013, Pages 1602-1611

  Berntsson, Ronnie Per Arne ^a   Peng, Lisheng ^b   Svensson, Linda Marie ^a   Dong, Min ^b   Stenmark, Pål ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN DC; GANGLIOSIDE; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ESCHERICHIA COLI; HYDROPHOBICITY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; CRYSTALLOGRAPHY, X-RAY; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RATS; STRUCTURAL HOMOLOGY, PROTEIN; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II;

EID: 84883489320     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2013.06.026     Document Type: Article

References (53)

1. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, J. Hauer, and M. Layton Botulinum toxin as a biological weapon: medical and public health management JAMA 285 2001 1059 1070
2. M.A. Benson, Z. Fu, J.-J.P. Kim, and M.R. Baldwin Unique ganglioside recognition strategies for clostridial neurotoxins J. Biol. Chem. 286 2011 34015 34022
3. Q. Chai, J.W. Arndt, M. Dong, W.H. Tepp, E.A. Johnson, E.R. Chapman, and R.C. Stevens Structural basis of cell surface receptor recognition by botulinum neurotoxin B Nature 444 2006 1096 1100
4. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallogr. D Biol. Crystallogr. 50 1994 760 763
5. M. Craxton A manual collection of Syt, Esyt, Rph3a, Rph3al, Doc2, and Dblc2 genes from 46 metazoan genomes - an open access resource for neuroscience and evolutionary biology BMC Genomics 11 2010 37
6. J.O. Dolly, G.W. Lawrence, J. Meng, J. Wang, and S.V. Ovsepian Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics Curr. Opin. Pharmacol. 9 2009 326 335
7. M. Dong, D.A. Richards, M.C. Goodnough, W.H. Tepp, E.A. Johnson, and E.R. Chapman Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells J. Cell Biol. 162 2003 1293 1303
8. M. Dong, F. Yeh, W.H. Tepp, C. Dean, E.A. Johnson, R. Janz, and E.R. Chapman SV2 is the protein receptor for botulinum neurotoxin A Science 312 2006 592 596
9. M. Dong, H. Liu, W.H. Tepp, E.A. Johnson, R. Janz, and E.R. Chapman Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons Mol. Biol. Cell 19 2008 5226 5237
10. P. Emsley, and K. Cowtan Coot: model-building tools for molecular graphics Acta Crystallogr. D Biol. Crystallogr. 60 2004 2126 2132
11. C. Fotinou, P. Emsley, I. Black, H. Ando, H. Ishida, M. Kiso, K.A. Sinha, N.F. Fairweather, and N.W. Isaacs The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin J. Biol. Chem. 276 2001 32274 32281
12. Z. Fu, C. Chen, J.T. Barbieri, J.-J.P. Kim, and M.R. Baldwin Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F Biochemistry 48 2009 5631 5641
13. D.M. Gill Bacterial toxins: a table of lethal amounts Microbiol. Rev. 46 1982 86 94
14. K.K. Hill, T.J. Smith, C.H. Helma, L.O. Ticknor, B.T. Foley, R.T. Svensson, J.L. Brown, E.A. Johnson, L.A. Smith, and R.T. Okinaka Genetic diversity among Botulinum Neurotoxin-producing clostridial strains J. Bacteriol. 189 2007 818 832
15. M.J. Jacobson, G. Lin, B. Raphael, J. Andreadis, and E.A. Johnson Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes Appl. Environ. Microbiol. 74 2008 2778 2786
16. R. Jin, A. Rummel, T. Binz, and A.T. Brunger Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity Nature 444 2006 1092 1095
17. E.A. Johnson Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins Annu. Rev. Microbiol. 53 1999 551 575
18. W. Kabsch XDS Acta Crystallogr. D Biol. Crystallogr. 66 2010 125 132
19. A.P.-A. Karalewitz, A.R. Kroken, Z. Fu, M.R. Baldwin, J.-J.P. Kim, and J.T. Barbieri Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA Biochemistry 49 2010 8117 8126
20. A.P.-A. Karalewitz, Z. Fu, M.R. Baldwin, J.-J.P. Kim, and J.T. Barbieri Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry J. Biol. Chem. 287 2012 40806 40816
21. A.R. Kroken, A.P.-A. Karalewitz, Z. Fu, M.R. Baldwin, J.-J.P. Kim, and J.T. Barbieri Unique ganglioside binding by botulinum neurotoxins C and D-SA FEBS J. 278 2011 4486 4496
22. A.R. Kroken, A.P.-A. Karalewitz, Z. Fu, J.-J.P. Kim, and J.T. Barbieri Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons J. Biol. Chem. 286 2011 26828 26837
23. S. Mahrhold, A. Rummel, H. Bigalke, B. Davletov, and T. Binz The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves FEBS Lett. 580 2006 2011 2014
24. M. Montal Botulinum neurotoxin: a marvel of protein design Annu. Rev. Biochem. 79 2010 591 617
25. C. Montecucco How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci. 11 1986 314 317
26. K. Moriishi, M. Koura, N. Abe, N. Fujii, Y. Fujinaga, K. Inoue, and K. Ogumad Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms Biochim. Biophys. Acta 1307 1996 123 126
27. L. Muraro, S. Tosatto, L. Motterlini, O. Rossetto, and C. Montecucco The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane Biochem. Biophys. Res. Commun. 380 2009 76 80
28. G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallogr. D Biol. Crystallogr. 53 1997 240 255
29. T. Nishiki, J. Ogasawara, Y. Kamata, and S. Kozaki Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes Biochim. Biophys. Acta 1158 1993 333 338
30. T. Nishiki, Y. Kamata, Y. Nemoto, A. Omori, T. Ito, M. Takahashi, and S. Kozaki Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes J. Biol. Chem. 269 1994 10498 10503
31. T. Nishiki, Y. Tokuyama, Y. Kamata, Y. Nemoto, A. Yoshida, M. Sekiguchi, M. Takahashi, and S. Kozaki Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA Neurosci. Lett. 208 1996 105 108
32. N. Nuemket, Y. Tanaka, K. Tsukamoto, T. Tsuji, K. Nakamura, S. Kozaki, M. Yao, and I. Tanaka Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: insight into the ganglioside binding mechanism Biochem. Biophys. Res. Commun. 411 2011 433 439
33. L. Peng, W.H. Tepp, E.A. Johnson, and M. Dong Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors PLoS Pathog. 7 2011 e1002008
34. L. Peng, R.P.-A. Berntsson, W.H. Tepp, R.M. Pitkin, E.A. Johnson, P. Stenmark, and M. Dong Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins J. Cell Sci. 125 2012 3233 3242
35. A. Rummel, T. Karnath, T. Henke, H. Bigalke, and T. Binz Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G J. Biol. Chem. 279 2004 30865 30870
36. A. Rummel, S. Mahrhold, H. Bigalke, and T. Binz The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction Mol. Microbiol. 51 2004 631 643
37. A. Rummel, K. Häfner, S. Mahrhold, N. Darashchonak, M. Holt, R. Jahn, S. Beermann, T. Karnath, H. Bigalke, and T. Binz Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor J. Neurochem. 110 2009 1942 1954
38. G. Schiavo, M. Matteoli, and C. Montecucco Neurotoxins affecting neuroexocytosis Physiol. Rev. 80 2000 717 766
39. J. Schmitt, A. Karalewitz, D.A. Benefield, D.J. Mushrush, R.N. Pruitt, B.W. Spiller, J.T. Barbieri, and D.B. Lacy Structural analysis of botulinum neurotoxin type G receptor binding Biochemistry 49 2010 5200 5205
40. T.J. Smith, J. Lou, I.N. Geren, C.M. Forsyth, R. Tsai, S.L. Laporte, W.H. Tepp, M. Bradshaw, E.A. Johnson, L.A. Smith, and J.D. Marks Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization Infect. Immun. 73 2005 5450 5457
41. P. Stenmark, J. Dupuy, A. Imamura, M. Kiso, and R.C. Stevens Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction PLoS Pathog. 4 2008 e1000129
42. P. Stenmark, M. Dong, J. Dupuy, E.R. Chapman, and R.C. Stevens Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding J. Mol. Biol. 397 2010 1287 1297
43. J. Strotmeier, K. Lee, A.K. Völker, S. Mahrhold, Y. Zong, J. Zeiser, J. Zhou, A. Pich, H. Bigalke, and T. Binz Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner Biochem. J. 431 2010 207 216
44. J. Strotmeier, S. Gu, S. Jutzi, S. Mahrhold, J. Zhou, A. Pich, T. Eichner, H. Bigalke, A. Rummel, R. Jin, and T. Binz The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites Mol. Microbiol. 81 2011 143 156
45. J. Strotmeier, G. Willjes, T. Binz, and A. Rummel Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity FEBS Lett. 586 2012 310 313
46. S. Swaminathan Molecular structures and functional relationships in clostridial neurotoxins FEBS J. 278 2011 4467 4485
47. S. Swaminathan, and S. Eswaramoorthy Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B Nat. Struct. Biol. 7 2000 693 699
48. K. Tsukamoto, T. Kohda, M. Mukamoto, K. Takeuchi, H. Ihara, M. Saito, and S. Kozaki Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins J. Biol. Chem. 280 2005 35164 35171
49. M.D. Winn, M.N. Isupov, and G.N. Murshudov Use of TLS parameters to model anisotropic displacements in macromolecular refinement Acta Crystallogr. D Biol. Crystallogr. 57 2001 122 133
50. F.L. Yeh, M. Dong, J. Yao, W.H. Tepp, G. Lin, E.A. Johnson, and E.R. Chapman SV2 mediates entry of tetanus neurotoxin into central neurons PLoS Pathog. 6 2010 e1001207
51. Y. Zhang, and S.M. Varnum The receptor binding domain of botulinum neurotoxin serotype C binds phosphoinositides Biochimie 94 2012 920 923
52. Y. Zhang, G.W. Buchko, L. Qin, H. Robinson, and S.M. Varnum Structural analysis of the receptor binding domain of botulinum neurotoxin serotype D Biochem. Biophys. Res. Commun. 401 2010 498 503
53. Y. Zhang, G.W. Buchko, L. Qin, H. Robinson, and S.M. Varnum Crystal structure of the receptor binding domain of the botulinum C-D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions Biochem. Biophys. Res. Commun. 404 2011 407 412